Gabapentin Capsule
Product Images NDC 63629-8485

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8485). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A line graph showing mean pain scores over an 8-week period comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin-treated scores decrease steadily compared to placebo.*

FDA Label Image

Figure 2 (Image 02)

A line graph showing mean pain scores over 7 weeks. The x-axis represents weeks from baseline to week 7, while the y-axis shows mean pain scores from 0 to 10. The graph compares placebo with gabapentin at doses of 1800 mg/day and 2400 mg/day, illustrating dose titration during the first 3 weeks and a fixed dose period for weeks 4 to 7.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing placebo (PBO) and Gabapentin (GBP) dosages in two studies. The chart shows percentages on the vertical axis and study groups on the horizontal axis, highlighting responder proportions for placebo and Gabapentin at 1800 mg, 2400 mg, and 3600 mg doses with statistical significance markers.*

FDA Label Image

Cockcroft And Gault Equation (Image 04)

A mathematical formula showing the calculation of creatinine clearance (CLCr) based on age, weight, serum creatinine, and sex adjustment factor, depicted as an equation involving these variables.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure diagram of Gabapentin showing the molecular arrangement with a cyclohexane ring bonded to side chains including CH2NH2 and CH2CO2H groups.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the difference percentage on the vertical axis and daily dose in milligrams on the horizontal axis. The chart includes data points from three different studies labeled as Study a, Study b, and Study c, with doses ranging from 600 mg to 1800 mg and difference percentages from about 7% to 18%.*

FDA Label Image

Label (Lbl636298485)

Label for Gabapentin Capsules, USP 100 mg oral capsules, manufactured by Bryant Ranch Prepack and relabeled by BRP Pharmaceuticals. The label includes storage instructions, child-resistant closure information, a barcode, and states the package contains 100 capsules for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.